Brief: FDA Confirms Date To Providing Regulatory Guidance For Aequus’ Anti-Nausea Patch
March 7 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* FDA CONFIRMS DATE TO PROVIDING REGULATORY GUIDANCE FOR
AEQUUS’
ANTI-NAUSEA PATCH
* AEQUUS PHARMACEUTICALS - FDA WILL PROVIDE FEEDBACK TO CO'S
PRE-INVESTIGATIONAL NEW DRUG SUBMISSION BY APRIL END, 2018 FOR
AQS1303
Source text for Eikon: ID:nGNXbYp0f9
Further company coverage: AQS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange